Bluejay Diagnostics, Inc. Accounts Payable
Bluejay Diagnostics, Inc. (BJDX) had Accounts Payable of $674.09 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $674.09K.
- 2026-03-31: Accounts Payable, Current $220.29K.
- 2025-12-31: Accounts Payable, Current $214.25K.
- 2025-09-30: Accounts Payable, Current $161.16K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $674.09K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $220.29K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $214.25K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $161.16K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $108.82K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $519.52K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $145.12K 10-K · filed 2026-03-06 |
| 2024-09-30 | $316.65K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $490.06K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $271.82K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $491.47K 10-K · filed 2025-03-31 |
| 2023-09-30 | $755.95K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $271.49K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $388.05K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $635.82K 10-K · filed 2024-03-28 |
| 2022-09-30 | $443.04K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $196.11K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $716.84K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $295.78K 10-K · filed 2023-03-20 |
| 2021-09-30 | $242.86K 10-Q · filed 2021-12-16 |
| 2020-12-31 | $374.93K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |